Titre : Sphingolipides

Sphingolipides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Models, Theoretical

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une maladie liée aux sphingolipides ?

Le diagnostic repose sur des tests génétiques, des analyses biochimiques et des biopsies.
Maladies métaboliques Sphingolipides
#2

Quels tests sont utilisés pour évaluer les sphingolipides ?

Des tests sanguins et des analyses d'urine mesurent les niveaux de sphingolipides.
Analyse sanguine Sphingolipides
#3

Les symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?

Oui, des symptômes neurologiques ou cutanés peuvent signaler un déséquilibre.
Symptômes neurologiques Sphingolipides
#4

Quelle imagerie est utile pour les maladies des sphingolipides ?

L'IRM et la TDM peuvent aider à visualiser les effets des maladies sur les organes.
Imagerie par résonance magnétique Sphingolipides
#5

Les antécédents familiaux sont-ils importants pour le diagnostic ?

Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique aux maladies.
Antécédents familiaux Sphingolipides

Symptômes 5

#1

Quels sont les symptômes des troubles liés aux sphingolipides ?

Les symptômes incluent des troubles neurologiques, des problèmes cutanés et des douleurs.
Symptômes neurologiques Sphingolipides
#2

Les troubles digestifs sont-ils associés aux sphingolipides ?

Oui, certains troubles digestifs peuvent être liés à des anomalies des sphingolipides.
Troubles digestifs Sphingolipides
#3

Comment les sphingolipides affectent-ils le système nerveux ?

Ils jouent un rôle dans la myélinisation et la signalisation neuronale, affectant la fonction nerveuse.
Système nerveux Sphingolipides
#4

Les troubles de la peau sont-ils fréquents avec les sphingolipides ?

Oui, des affections cutanées comme l'eczéma peuvent être liées à des déséquilibres.
Affections cutanées Sphingolipides
#5

Les symptômes varient-ils selon le type de sphingolipide ?

Oui, les symptômes dépendent du type de sphingolipide impliqué et de l'organe affecté.
Types de sphingolipides Sphingolipides

Prévention 5

#1

Peut-on prévenir les maladies liées aux sphingolipides ?

La prévention est difficile, mais un mode de vie sain peut réduire les risques.
Prévention des maladies Sphingolipides
#2

Les tests génétiques aident-ils à la prévention ?

Oui, les tests génétiques peuvent identifier les personnes à risque et guider la prévention.
Tests génétiques Sphingolipides
#3

L'éducation sur les sphingolipides est-elle importante ?

Oui, comprendre les sphingolipides aide à reconnaître les symptômes et à agir rapidement.
Éducation à la santé Sphingolipides
#4

Les habitudes alimentaires influencent-elles la santé des sphingolipides ?

Oui, une alimentation équilibrée peut soutenir la santé des sphingolipides et prévenir des troubles.
Habitudes alimentaires Sphingolipides
#5

Les vaccinations peuvent-elles aider à prévenir des complications ?

Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles liés aux sphingolipides.
Vaccination Sphingolipides

Traitements 5

#1

Quels traitements existent pour les maladies des sphingolipides ?

Les traitements incluent des thérapies enzymatiques, des médicaments et des soins symptomatiques.
Thérapie enzymatique Sphingolipides
#2

La diète peut-elle influencer les niveaux de sphingolipides ?

Oui, une alimentation riche en acides gras essentiels peut aider à réguler les sphingolipides.
Régime alimentaire Sphingolipides
#3

Les médicaments peuvent-ils réduire les symptômes ?

Oui, certains médicaments peuvent atténuer les symptômes et améliorer la qualité de vie.
Médicaments Sphingolipides
#4

Y a-t-il des traitements expérimentaux pour ces maladies ?

Oui, des essais cliniques explorent de nouvelles thérapies pour les troubles des sphingolipides.
Essais cliniques Sphingolipides
#5

La thérapie génique est-elle une option pour ces maladies ?

La thérapie génique est en recherche pour traiter certaines maladies liées aux sphingolipides.
Thérapie génique Sphingolipides

Complications 5

#1

Quelles complications peuvent survenir avec les troubles des sphingolipides ?

Les complications incluent des troubles neurologiques graves, des infections et des défaillances organiques.
Complications Sphingolipides
#2

Les troubles respiratoires sont-ils une complication possible ?

Oui, certains troubles des sphingolipides peuvent entraîner des complications respiratoires.
Troubles respiratoires Sphingolipides
#3

Comment les sphingolipides affectent-ils le cœur ?

Des déséquilibres peuvent contribuer à des maladies cardiovasculaires et à des arythmies.
Maladies cardiovasculaires Sphingolipides
#4

Les complications neurologiques sont-elles fréquentes ?

Oui, des complications comme la démence ou des troubles moteurs peuvent survenir.
Complications neurologiques Sphingolipides
#5

Les complications peuvent-elles être réversibles ?

Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles.
Réversibilité Sphingolipides

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les maladies des sphingolipides ?

Les facteurs incluent des antécédents familiaux, des mutations génétiques et des déséquilibres nutritionnels.
Facteurs de risque Sphingolipides
#2

L'âge influence-t-il le risque de troubles des sphingolipides ?

Oui, certains troubles apparaissent plus fréquemment chez les enfants ou les personnes âgées.
Âge Sphingolipides
#3

Les maladies auto-immunes sont-elles un facteur de risque ?

Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles liés aux sphingolipides.
Maladies auto-immunes Sphingolipides
#4

Le mode de vie influence-t-il le risque ?

Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque.
Mode de vie Sphingolipides
#5

Les infections peuvent-elles aggraver les troubles des sphingolipides ?

Oui, certaines infections peuvent exacerber les symptômes et les complications.
Infections Sphingolipides
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sphingolipides : Questions médicales les plus fréquentes", "headline": "Sphingolipides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sphingolipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sphingolipides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lipides membranaires", "url": "https://questionsmedicales.fr/mesh/D008563", "about": { "@type": "MedicalCondition", "name": "Lipides membranaires", "code": { "@type": "MedicalCode", "code": "D008563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosphingolipides", "alternateName": "Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D006028", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides", "code": { "@type": "MedicalCode", "code": "D006028", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosphingolipides acides", "alternateName": "Acidic Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D020384", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides acides", "code": { "@type": "MedicalCode", "code": "D020384", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Gangliosides", "alternateName": "Gangliosides", "url": "https://questionsmedicales.fr/mesh/D005732", "about": { "@type": "MedicalCondition", "name": "Gangliosides", "code": { "@type": "MedicalCode", "code": "D005732", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } }, { "@type": "MedicalWebPage", "name": "Sulfoglycosphingolipides", "alternateName": "Sulfoglycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D013433", "about": { "@type": "MedicalCondition", "name": "Sulfoglycosphingolipides", "code": { "@type": "MedicalCode", "code": "D013433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.837" } } } ] }, { "@type": "MedicalWebPage", "name": "Gangliosides", "alternateName": "Gangliosides", "url": "https://questionsmedicales.fr/mesh/D005732", "about": { "@type": "MedicalCondition", "name": "Gangliosides", "code": { "@type": "MedicalCode", "code": "D005732", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } }, { "@type": "MedicalWebPage", "name": "Sulfoglycosphingolipides", "alternateName": "Sulfoglycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D013433", "about": { "@type": "MedicalCondition", "name": "Sulfoglycosphingolipides", "code": { "@type": "MedicalCode", "code": "D013433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.837" } } }, { "@type": "MedicalWebPage", "name": "Glycosphingolipides neutres", "alternateName": "Neutral Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D020383", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides neutres", "code": { "@type": "MedicalCode", "code": "D020383", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Céramides", "alternateName": "Ceramides", "url": "https://questionsmedicales.fr/mesh/D002518", "about": { "@type": "MedicalCondition", "name": "Céramides", "code": { "@type": "MedicalCode", "code": "D002518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } } ] }, { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } }, { "@type": "MedicalWebPage", "name": "Sphingomyéline", "alternateName": "Sphingomyelins", "url": "https://questionsmedicales.fr/mesh/D013109", "about": { "@type": "MedicalCondition", "name": "Sphingomyéline", "code": { "@type": "MedicalCode", "code": "D013109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.870" } } } ] }, { "@type": "MedicalWebPage", "name": "Céramides", "alternateName": "Ceramides", "url": "https://questionsmedicales.fr/mesh/D002518", "about": { "@type": "MedicalCondition", "name": "Céramides", "code": { "@type": "MedicalCode", "code": "D002518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } } ] }, { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } }, { "@type": "MedicalWebPage", "name": "Sphingomyéline", "alternateName": "Sphingomyelins", "url": "https://questionsmedicales.fr/mesh/D013109", "about": { "@type": "MedicalCondition", "name": "Sphingomyéline", "code": { "@type": "MedicalCode", "code": "D013109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.870" } } }, { "@type": "MedicalWebPage", "name": "Psychosine", "alternateName": "Psychosine", "url": "https://questionsmedicales.fr/mesh/D011609", "about": { "@type": "MedicalCondition", "name": "Psychosine", "code": { "@type": "MedicalCode", "code": "D011609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.806" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Sphingolipides", "alternateName": "Sphingolipids", "code": { "@type": "MedicalCode", "code": "D013107", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Erich Gulbins", "url": "https://questionsmedicales.fr/author/Erich%20Gulbins", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany." } }, { "@type": "Person", "name": "Giovanni D'Angelo", "url": "https://questionsmedicales.fr/author/Giovanni%20D%27Angelo", "affiliation": { "@type": "Organization", "name": "Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt." } }, { "@type": "Person", "name": "Anna Kovilakath", "url": "https://questionsmedicales.fr/author/Anna%20Kovilakath", "affiliation": { "@type": "Organization", "name": "Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States." } }, { "@type": "Person", "name": "L Ashley Cowart", "url": "https://questionsmedicales.fr/author/L%20Ashley%20Cowart", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States." } }, { "@type": "Person", "name": "Tyrone Dowdy", "url": "https://questionsmedicales.fr/author/Tyrone%20Dowdy", "affiliation": { "@type": "Organization", "name": "Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Theoretical model of external spinal cord stimulation.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35671753", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1088/1478-3975/ac768e" } }, { "@type": "ScholarlyArticle", "name": "Building a theoretical model for virtual interprofessional education.", "datePublished": "2022-07-14", "url": "https://questionsmedicales.fr/article/35789027", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/medu.14867" } }, { "@type": "ScholarlyArticle", "name": "Theoretical model for management of nursing research groups.", "datePublished": "2023-09-18", "url": "https://questionsmedicales.fr/article/37729268", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1983-1447.2023.20220254.en" } }, { "@type": "ScholarlyArticle", "name": "Theoretical Study Theory of professional bonds: description and theoretical analysis based on the Meleis' model with Delphi strategy.", "datePublished": "2022-06-03", "url": "https://questionsmedicales.fr/article/35666984", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1980-220X-REEUSP-2022-0054en" } }, { "@type": "ScholarlyArticle", "name": "Explaining public dental service utilization: A theoretical model.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37656715", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0290992" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Lipides membranaires", "item": "https://questionsmedicales.fr/mesh/D008563" }, { "@type": "ListItem", "position": 4, "name": "Sphingolipides", "item": "https://questionsmedicales.fr/mesh/D013107" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sphingolipides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sphingolipides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sphingolipides", "description": "Comment diagnostiquer une maladie liée aux sphingolipides ?\nQuels tests sont utilisés pour évaluer les sphingolipides ?\nLes symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?\nQuelle imagerie est utile pour les maladies des sphingolipides ?\nLes antécédents familiaux sont-ils importants pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Models,+Theoretical#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sphingolipides", "description": "Quels sont les symptômes des troubles liés aux sphingolipides ?\nLes troubles digestifs sont-ils associés aux sphingolipides ?\nComment les sphingolipides affectent-ils le système nerveux ?\nLes troubles de la peau sont-ils fréquents avec les sphingolipides ?\nLes symptômes varient-ils selon le type de sphingolipide ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Models,+Theoretical#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sphingolipides", "description": "Peut-on prévenir les maladies liées aux sphingolipides ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation sur les sphingolipides est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des sphingolipides ?\nLes vaccinations peuvent-elles aider à prévenir des complications ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Models,+Theoretical#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sphingolipides", "description": "Quels traitements existent pour les maladies des sphingolipides ?\nLa diète peut-elle influencer les niveaux de sphingolipides ?\nLes médicaments peuvent-ils réduire les symptômes ?\nY a-t-il des traitements expérimentaux pour ces maladies ?\nLa thérapie génique est-elle une option pour ces maladies ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Models,+Theoretical#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sphingolipides", "description": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?\nLes troubles respiratoires sont-ils une complication possible ?\nComment les sphingolipides affectent-ils le cœur ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être réversibles ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Models,+Theoretical#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sphingolipides", "description": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?\nL'âge influence-t-il le risque de troubles des sphingolipides ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles aggraver les troubles des sphingolipides ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Models,+Theoretical#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie liée aux sphingolipides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques, des analyses biochimiques et des biopsies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les sphingolipides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses d'urine mesurent les niveaux de sphingolipides." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes neurologiques ou cutanés peuvent signaler un déséquilibre." } }, { "@type": "Question", "name": "Quelle imagerie est utile pour les maladies des sphingolipides ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et la TDM peuvent aider à visualiser les effets des maladies sur les organes." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils importants pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique aux maladies." } }, { "@type": "Question", "name": "Quels sont les symptômes des troubles liés aux sphingolipides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des problèmes cutanés et des douleurs." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils associés aux sphingolipides ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles digestifs peuvent être liés à des anomalies des sphingolipides." } }, { "@type": "Question", "name": "Comment les sphingolipides affectent-ils le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils jouent un rôle dans la myélinisation et la signalisation neuronale, affectant la fonction nerveuse." } }, { "@type": "Question", "name": "Les troubles de la peau sont-ils fréquents avec les sphingolipides ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des affections cutanées comme l'eczéma peuvent être liées à des déséquilibres." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de sphingolipide ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent du type de sphingolipide impliqué et de l'organe affecté." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies liées aux sphingolipides ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque et guider la prévention." } }, { "@type": "Question", "name": "L'éducation sur les sphingolipides est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre les sphingolipides aide à reconnaître les symptômes et à agir rapidement." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la santé des sphingolipides ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut soutenir la santé des sphingolipides et prévenir des troubles." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider à prévenir des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles liés aux sphingolipides." } }, { "@type": "Question", "name": "Quels traitements existent pour les maladies des sphingolipides ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies enzymatiques, des médicaments et des soins symptomatiques." } }, { "@type": "Question", "name": "La diète peut-elle influencer les niveaux de sphingolipides ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en acides gras essentiels peut aider à réguler les sphingolipides." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils réduire les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent atténuer les symptômes et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux pour ces maladies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des essais cliniques explorent de nouvelles thérapies pour les troubles des sphingolipides." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces maladies ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour traiter certaines maladies liées aux sphingolipides." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques graves, des infections et des défaillances organiques." } }, { "@type": "Question", "name": "Les troubles respiratoires sont-ils une complication possible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles des sphingolipides peuvent entraîner des complications respiratoires." } }, { "@type": "Question", "name": "Comment les sphingolipides affectent-ils le cœur ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres peuvent contribuer à des maladies cardiovasculaires et à des arythmies." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme la démence ou des troubles moteurs peuvent survenir." } }, { "@type": "Question", "name": "Les complications peuvent-elles être réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des déséquilibres nutritionnels." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de troubles des sphingolipides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles apparaissent plus fréquemment chez les enfants ou les personnes âgées." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles liés aux sphingolipides." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver les troubles des sphingolipides ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent exacerber les symptômes et les complications." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 10/03/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

17 au total
└─

Glycosphingolipides

Glycosphingolipids D006028 - D10.570.877.360
└─└─

Glycosphingolipides acides

Acidic Glycosphingolipids D020384 - D10.570.877.360.025
└─└─

Glycosphingolipides neutres

Neutral Glycosphingolipids D020383 - D10.570.877.360.612
└─└─

Psychosine

Psychosine D011609 - D10.570.877.360.806
└─└─└─

Gangliosides

Gangliosides D005732 - D10.570.877.360.025.475
└─└─└─

Sulfoglycosphingolipides

Sulfoglycosphingolipids D013433 - D10.570.877.360.025.837
└─└─└─

Céramides

Ceramides D002518 - D10.570.877.360.612.200
└─└─└─

Sphingomyéline

Sphingomyelins D013109 - D10.570.877.360.612.870
└─└─└─└─

Ganglioside GM1

G(M1) Ganglioside D005677 - D10.570.877.360.025.475.390
└─└─└─└─

Ganglioside GM2

G(M2) Ganglioside D005678 - D10.570.877.360.025.475.400
└─└─└─└─

Ganglioside GM3

G(M3) Ganglioside D005679 - D10.570.877.360.025.475.510
└─└─└─└─

Cérébrosides

Cerebrosides D002554 - D10.570.877.360.612.200.250
└─└─└─└─

Globosides

Globosides D005915 - D10.570.877.360.612.200.425
└─└─└─└─

Lactosylcéramides

Lactosylceramides D007790 - D10.570.877.360.612.200.612
└─└─└─└─

Trihexosylcéramide

Trihexosylceramides D014281 - D10.570.877.360.612.200.906
└─└─└─└─└─

Galactosylcéramides

Galactosylceramides D005699 - D10.570.877.360.612.200.250.450
└─└─└─└─└─

Glucosylcéramides

Glucosylceramides D005963 - D10.570.877.360.612.200.250.490

Auteurs principaux

Erich Gulbins

3 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
  • Department of Surgery, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Sphingolipides" :

Giovanni D'Angelo

3 publications dans cette catégorie

Affiliations :
  • Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt.
Publications dans "Sphingolipides" :

Anna Kovilakath

3 publications dans cette catégorie

Affiliations :
  • Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States.
Publications dans "Sphingolipides" :

L Ashley Cowart

3 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
  • Richmond Veteran's Affairs Medical Center, Richmond, VA, United States.
Publications dans "Sphingolipides" :

Tyrone Dowdy

3 publications dans cette catégorie

Affiliations :
  • Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Publications dans "Sphingolipides" :

Mioara Larion

3 publications dans cette catégorie

Affiliations :
  • Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Publications dans "Sphingolipides" :

Anthony H Futerman

2 publications dans cette catégorie

Affiliations :
  • Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Publications dans "Sphingolipides" :

Burkhard Kleuser

2 publications dans cette catégorie

Affiliations :
  • Department of Toxicology, University of Potsdam, Nuthetal, Germany.
Publications dans "Sphingolipides" :

Fabian Schumacher

2 publications dans cette catégorie

Affiliations :
  • Department of Toxicology, University of Potsdam, Nuthetal, Germany.
  • Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
Publications dans "Sphingolipides" :

Hugo J Bellen

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
  • Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, United States.
  • Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States.
Publications dans "Sphingolipides" :

Stuart M Pitson

2 publications dans cette catégorie

Affiliations :
  • Centre for Cancer Biology, University of South Australia and SA Pathology, UniSA CRI Building, North Tce, Adelaide, SA 5001, Australia; Adelaide Medical School, University of Adelaide, Adelaide, SA 5001, Australia; School of Biological Sciences, University of Adelaide, Adelaide, SA 5000, Australia. Electronic address: stuart.pitson@unisa.edu.au.
Publications dans "Sphingolipides" :

Melissa Vos

2 publications dans cette catégorie

Affiliations :
  • Institute of Neurogenetics, University of Luebeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Publications dans "Sphingolipides" :

Adrian Lita

2 publications dans cette catégorie

Publications dans "Sphingolipides" :

Lumin Zhang

2 publications dans cette catégorie

Publications dans "Sphingolipides" :

Mark R Gilbert

2 publications dans cette catégorie

Publications dans "Sphingolipides" :

Nawajes Mandal

2 publications dans cette catégorie

Affiliations :
  • Department of Ophthalmology, University of Tennessee Health Science Center, UTHSC, Memphis, TN, USA. nmandal@uthsc.edu.
  • Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, UTHSC, Memphis, TN, USA. nmandal@uthsc.edu.

Maryam Jamil

2 publications dans cette catégorie

Affiliations :
  • Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States.
  • Department of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
Publications dans "Sphingolipides" :

Lauren Ashley Cowart

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
  • Richmond Veteran's Affairs Medical Center, Richmond, VA, United States.
Publications dans "Sphingolipides" :

Miroslav Machala

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.

Jiřina Procházková

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.

Sources (10000 au total)

Building a theoretical model for virtual interprofessional education.

Virtual interprofessional education (IPE) has emerged as a promising alternative to traditional in-person IPE. However, theoretical frameworks to support virtual interprofessional learning are not wel... This was a qualitative study. Semi-structured interviews were conducted with medical and nursing student participants (n = 14) and facilitators (n = 3) from virtual IPE workshops. Transcripts were ana... Three themes were identified: (1) a shift in the balance of personal and professional, (2) blunted sociologic fidelity and (3) uncertainty and threats to interpersonal connections. Professional distin... Role clarification and communication objectives are preserved in virtual IPE. Educators should pay close attention to psychological safety and sociologic fidelity-both to leverage advantages and guard...

Theoretical model for management of nursing research groups.

To develop a theoretical model for management of research groups in nursing graduate programs.... This is a Grounded Theory developed in a stricto sensu nursing graduate program of a public university. Data collection was conducted from April to October 2018 and the theoretical sample consisted of... Research activities are linked to research groups, which require human, material and financial resources to develop their studies. These conditions call for management strategies and national and inte... The theoretical model for management of research groups can serve as a guide for graduate programs in nursing and health for planning the work process and so that they can contribute with research of ...

Explaining public dental service utilization: A theoretical model.

Constructing and validating a theoretical model of relationships between dental services use and socioeconomic characteristics, oral health status, primary care coverage, and public dental services.... The first stage of the study consisted of developing a theoretical-conceptual model to demonstrate the expected relationships between variables based on the literature. In the second stage, we tested ... This study successfully defined a theoretical model that explains the systematic relationships involving public dental services utilization. Socioeconomic status was negatively associated with oral he... The identified relationships, establishing a theoretical basis for further investigations, also provide evidence of a public access policy's effect on oral health services on equity, supporting the co...

Investigating inflammation in depression in the chronically ill: Theoretical model and perspectives.

Inflammation is a risk factor for chronic physical illnesses. Evidence is building that inflammation is also a risk factor for mental illnesses making inflammation a common mechanism which could expla... Based on a systematic search, a review on factors associated with inflammation in the depressed chronically ill has been conducted. Relevant articles have been selected according to the methodological... Five categories of factors mediate the association between chronic physical and mental illnesses: (1) social-demographic factors, (2) social-economic background, (3) adverse health behaviours, (4) psy... Inflammation contribute to both chronic physical and mental illnesses. These conclusions support future advances in clinical and research practice, as well as training and education....